Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Why the study?
How should rivaroxaban be used in day-to-day clinical practice for patients with nonvalvular atrial fibrillation?
Population
Patients with nonvalvular atrial fibrillation and one or more risk factors for stroke
Comparison
Rivaroxaban vs Vitamin K antagonists (e.g., warfarin)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Offers practical rivaroxaban guidance for nonvalvular AF; leaves open prospective validation of recommendations.
Structured PICO
How should rivaroxaban be used in day-to-day clinical practice for patients with nonvalvular atrial fibrillation?
P
Population
Patients with nonvalvular atrial fibrillation and one or more risk factors for stroke
I
Intervention
Rivaroxaban
C
Comparator
Vitamin K antagonists (e.g., warfarin)
This review provides practical, day-to-day clinical guidance for managing patients with nonvalvular atrial fibrillation treated with rivaroxaban.
Cite This Study
Haas et al. (2014) studied this question.